Correct. CHM is not linked to this article. I posted as I believe the majority of long-term posters here have an interest in GBM treatments on a wider scale and may find this article of interest if they have not already seen it.
Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-29
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable